United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Nordic Nanovector launches US Phase 2b trial for Betalutin in follicular lymphoma Nordic Nanovector, a Norwegian biopharmaceutical company, has commenced the first clinical site in the United States for its… bypharmanewsdailyOctober 28, 2018